Docetaxel Alone or in Combination With Vaccine to Treat Breast Cancer

NCT00179309 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

NIH

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Docetaxel
BIOLOGICAL: PANVAC-V
BIOLOGICAL: PANVAC-F
BIOLOGICAL: Sargramostim

Sponsor

National Cancer Institute (NCI)